Daniella Cramp

Daniella joined Thermo Fisher in 2019 as President, Instrument and Enterprise Services. In January 2021, she was named Senior Vice President and President, BioProduction.

Prior to joining Thermo Fisher, Daniella served as Global President for Johnson & Johnson’s (J&J’s) neurovascular medical device business and as U.S. President for Biosense Webster, J&J’s market-leading electrophysiology business. Prior to joining J&J, Daniella spent 17 years with Alere, where she most recently served as Global President of its cardiometabolic business.

Daniella earned an MBA from University of California, Irvine, and a bachelor’s degree from University of California, Riverside.